The treatment of pterygium.
The treatment of pterygium is still quite controversial, with various treatments being advocated in the scientific literature. Unfortunately, there are very few well-conducted controlled clinical trials of treatments. However, years of anecdotal and noncontrolled studies have confirmed that some methods, such as bare scleral closure, are no longer acceptable in the treatment of pterygium and that other methods are likely to be more useful. In the future it will be important to develop a grading system, and surgeons will need to be conservative in the treatment of pterygium until such time as a single treatment provides a lower recurrence rate and complication rate.
Hirst
Lawrence W
LW
University of Queensland, Divison of Ophthalmology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba 7, Queensland 4102, Australia.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003228:Conjunctiva / Q000601:surgery; D006801:Humans; D013508:Ophthalmologic Surgical Procedures / Q000379:methods; D011625:Pterygium / Q000628:therapy*; D012008:Recurrence; D013524:Surgical Flaps
D000970:Antineoplastic Agents